Access to Medicines and Vaccines Implementing Flexibilities Under Intellectual Property Law /
| Awdur Corfforaethol: | |
|---|---|
| Awduron Eraill: | , |
| Crynodeb: | X, 369 p. 3 illus. in color. text |
| Iaith: | Saesneg |
| Cyhoeddwyd: |
Cham :
Springer International Publishing : Imprint: Springer,
2022.
|
| Rhifyn: | 1st ed. 2022. |
| Pynciau: | |
| Mynediad Ar-lein: | https://doi.org/10.1007/978-3-030-83114-1 |
| Fformat: | Electronig eLyfr |
Tabl Cynhwysion:
- Interpreting the flexibilities under the TRIPS agreement
- Intellectual Property Exhaustion and Parallel Imports of Pharmaceuticals: A Comparative and Critical Review
- Compulsory license and government use
- Access to genome editing technologies
- Bolar exception
- Patent oppositions in India
- Protection of clinical test data
- Courts and Pharmaceutical Patents
- Robust Patent Examination or Deep Harmonization? Cooperation and Work Sharing between Patent Offices
- IPRs, Competition Law and excessive pricing of medicines
- The impact of TRIPS plus rules
- Patent Linkages and its Impact on Access to Medicines.